Biotech
PRAGUE, CZECH REPUBLIC: PRAGUE, CZECH REPUBLIC -- (Marketwired) -- 04/11/17 --Dortmund, Germany and Prague, Czech Republic, April 11, 2017 - The Lead Discovery Center GmbH (LDC), Max Planck Innovation GmbH (MI) and SOTIO a.s ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 04/11/17 -- Immunovaccine Inc. (TSX: IMV)(OTCQX: IMMVF), a clinical stage immuno-oncology company, today announced that University Health Network's (PM) ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/10/17 -- Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC)(FRANKFURT: 0E8) announces that ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 04/07/17 -- Immunovaccine Inc. (TSX: IMV)(OTCQX: IMMVF), a clinical stage immuno-oncology company, announced that will present an update on the Company' ...
EDMONTON, ALBERTA: Company reports highest full year revenues in Company's history and continues to deliver strong performance ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 04/06/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the first quarter ended February 28, 2017.First quarte ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 04/05/17 -- VBI Vaccines Inc. (NASDAQ: VBIV)(TSX: VBV) ("VBI") is scheduled to present updates on two of its programs at the on Tuesday, April ...
HALIFAX, NOVA SCOTIA: Study Part of Ongoing Effort to Identify Novel Combinations of DepoVax(TM)-based Immuno-oncology Candidates to Improve the Responses of Other Novel Immunotherapy Agents ...
GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 04/04/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)AIM: AGL; OTCQX: ANPCYThe Company has been informed by Lombard Odier Investment Managers group ("Lombard" ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 04/03/17 -- Atossa Genetics, Inc. (NASDAQ: ATOS) today announced the closing of its previously announced underwritten public offering with gross proceeds to Atossa of ...
SAN FRANCISCO, CA and LONDON, UNITED KINGDOM: SAN FRANCISCO, CA and LONDON, UNITED KINGDOM -- (Marketwired) -- 04/03/17 -- Treos Bio, which is developing precision therapeutic cancer vaccines coupled with companion diagnostics, today announced i ...
CITY OF INDUSTRY, CA: CITY OF INDUSTRY, CA -- (Marketwired) -- 04/03/17 -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for di ...
GUILDFORD, UNITED KINGDOM: GUILDFORD, UNITED KINGDOM -- (Marketwired) -- 04/03/17 -- Angle PLC (OTCQX: ANPCY) (AIM: AGL)AIM:AGL, OTCQX:ANPCYCustomer presents clinically relevant results at AACR 2017 with Parsortix where altern ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 03/31/17 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company focused on cancer risk assessment, a ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 03/30/17 -- Immunovaccine Inc. ("Immunovaccine" or the "Corporation") (TSX: IMV)(OTCQX: IMMVF), a clinical stage vaccine and immunotherapy ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 03/30/17 -- Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the first quarter ended February 28 ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 03/30/17 -- Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, announce ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 03/30/17 -- VBI Vaccines Inc. (NASDAQ: VBIV)(TSX: VBV) ("VBI") and ("SciVac"), a wholly owned subsidiary of VBI, are pleased to annou ...
PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 03/30/17 -- (NASDAQ: GNMX) (the Company) announced today that Brian D. Piper, Chief Financial Officer, will present at the 16th Annual Needham Healthcare Confere ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 03/30/17 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused primarily on the development of new products for inflammation, inbor ...
